Skip to main content Help with accessibility Skip to main navigation

NIRMATRELVIR plus RITONAVIR tablets (Paxlovid®▼), SOTROVIMAB solution for infusion (Xevudy®▼) and TOCILIZUMAB solution for infusion (RoActemra®▼) for treating COVID-19

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 29 - Jun - 2023
Body System:
Red
NIRMATRELVIR plus RITONAVIR tablets (Paxlovid®▼), SOTROVIMAB solution for infusion (Xevudy®▼) and TOCILIZUMAB solution for infusion (RoActemra®▼) for treating COVID-19

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of NIRMATRELVIR plus RITONAVIR tablets (Paxlovid®▼), SOTROVIMAB solution for infusion (Xevudy®▼) and TOCILIZUMAB solution for infusion (RoActemra®▼) by specialists only, for treating COVID-19 in accordance with NICE TA878.

NHS Cheshire and Merseyside APPROVED